Jaundice is one of the most common reasons for anxiety in the first days and weeks of breastfeeding. A yellowing newborn, a midwife who mentions phototherapy, and then — sometimes — a recommendation to supplement with formula or to stop breastfeeding temporarily. For many families, this is a difficult crossroads.
The evidence is clear that breastfeeding should continue through physiological jaundice in the vast majority of cases. Stopping breastfeeding to treat jaundice is almost never necessary and risks undermining a breastfeeding relationship at a particularly vulnerable time. The distinction between the two breastfeeding-related jaundice patterns, and between physiological and pathological jaundice, helps clarify what actually needs doing.
Healthbooq (healthbooq.com) covers breastfeeding and infant health in the newborn period.
Normal Newborn Jaundice
All newborns have higher bilirubin levels than adults because foetal haemoglobin breaks down after birth and the liver's ability to conjugate and excrete bilirubin is still maturing. The result is a temporary rise in unconjugated bilirubin causing visible yellowing of the skin and whites of the eyes (scleral icterus). This is physiological and affects approximately 60 per cent of term newborns.
Physiological jaundice appears after 24 hours of life (jaundice visible before 24 hours is pathological and always requires investigation), peaks around day three to four in formula-fed babies and slightly later in breastfed babies, and normally resolves by day ten to fourteen.
NICE CG98 provides the reference ranges (treatment thresholds) for when phototherapy is indicated, based on bilirubin level and gestational age.
Breastfeeding Jaundice (Early)
Breastfeeding jaundice occurs in the first week of life and is caused by inadequate calorie and fluid intake. When breastfeeding is not well established — insufficient milk transfer, poor latch, feeding too infrequently — the baby takes in fewer calories, has reduced gut motility, and excretes less bilirubin via the stool (meconium contains bilirubin). The result is higher bilirubin levels.
The management is increasing milk transfer, not stopping breastfeeding. This means: more frequent feeding (eight to twelve feeds per 24 hours), optimising latch with support from a midwife or lactation consultant, and monitoring weight and nappy output. If the baby is not gaining weight adequately or bilirubin is rising above treatment thresholds, supplementary expressed breast milk (or formula as a second option) is given while the underlying breastfeeding issue is addressed.
Phototherapy may be needed and is compatible with continuing breastfeeding. Interruptions to breastfeeding during phototherapy should be minimised; many units allow the baby to come out for feeds.
Breast Milk Jaundice (Late)
Breast milk jaundice is a distinct phenomenon, typically appearing after day four or five of life and persisting beyond two weeks — sometimes until six to twelve weeks. It affects approximately 10 to 15 per cent of breastfed babies. The mechanism involves factors in mature breast milk (including beta-glucuronidase and possibly other substances) that increase intestinal reabsorption of bilirubin and slow hepatic conjugation.
The key feature is that the baby with breast milk jaundice is otherwise entirely well: gaining weight normally, feeding effectively, having adequate wet and dirty nappies, and alert and vigorous. The jaundice is visible but the bilirubin level is usually below phototherapy threshold.
Prolonged jaundice (jaundice beyond two weeks in a term infant or three weeks in a preterm infant) should always be assessed to exclude pathological causes: conjugated hyperbilirubinaemia (dark urine, pale stools — this is always pathological and may indicate biliary atresia or other liver disease), hypothyroidism, haemolysis, and sepsis. A split bilirubin (conjugated and unconjugated fractions) should be measured.
Breast milk jaundice itself does not require treatment. Stopping breastfeeding is not recommended. If there is uncertainty about whether jaundice is breast milk jaundice or a pathological cause, a brief pause in breastfeeding (24 to 48 hours) to observe whether bilirubin falls may sometimes be used diagnostically, but this is unusual and should be balanced against the impact on breastfeeding.
Dark Urine and Pale Stools
These features — dark yellow or amber urine, pale or clay-coloured stools — in a jaundiced baby are red flags for conjugated jaundice and biliary pathology. Biliary atresia, in particular, requires surgical treatment (Kasai hepatoportoenterostomy) before eight weeks of age for the best outcomes. Any jaundiced baby with these features needs same-day urgent assessment.
Key Takeaways
Jaundice is more common in breastfed babies than formula-fed babies for two distinct reasons. Breastfeeding jaundice (early) occurs in the first week when insufficient milk intake leads to inadequate calorie intake and reduced bilirubin excretion. Breast milk jaundice (late) is a physiological phenomenon where factors in mature breast milk slow bilirubin conjugation, causing prolonged but usually benign jaundice in the second and third weeks. The key clinical question is always whether the jaundice is physiological or indicates an underlying pathology. Stopping breastfeeding to treat jaundice is rarely necessary and usually counterproductive.
